ストックスクリーナーアプリを入手
140.36
0.90%
1.46
Natera Inc (NTRA) 最新ニュース
Evercore ISI initiates Natera stock with Outperform rating, $170 price target - Investing.com Canada
Non-Invasive Prenatal Testing Market Forecast and Company - GlobeNewswire
Non-Invasive Prenatal Testing Market Forecast and Company Analysis Report 2025-2033 Featuring Eurofins Scientific, F. Hoffmann-La Roche, Invitae, Illumina, Natera, Centogene, and Qiagen - Yahoo Finance
Genetic testing company opens patient service center in Cumberland County - PennLive.com
What is the dividend policy of Natera Inc. stockCapitalize on market trends before they peak - jammulinksnews.com
How strong is Natera Inc. company’s balance sheetMaximize your portfolio’s growth with expert tips - jammulinksnews.com
What markets is Natera Inc. expanding into Is ATYR stock a good long term investment optionChart Pattern Recommendation For Smart Trading - jammulinksnews.com
How does Natera Inc. compare to its industry peersHigh-yield portfolio picks - jammulinksnews.com
What makes Natera Inc. stock price move sharplyProven Return Strategy Execution - metal.it
What is the risk reward ratio of investing in Natera Inc. stockGet professional advice for portfolio optimization - jammulinksnews.com
Published on: 2025-07-27 21:21:41 - jammulinksnews.com
When is Natera Inc. stock expected to show significant growthRapid wealth creation - jammulinksnews.com
What are Natera Inc. company’s key revenue driversTremendous return rates - jammulinksnews.com
Natera Maintains Strong Buy Rating from Leerink Partners Amid Insider Selling - AInvest
RBC Capital Maintains a Buy on Natera (NTRA) With a $251 PT - Insider Monkey
10 Best Strong Buy Healthcare Stocks to Buy Now - Insider Monkey
What analysts say about Natera Inc. stockTriple-digit growth rates - PrintWeekIndia
U.S. Minimal Residual Disease Testing Market Trends Analysis Report 2025-2033 | Integration with Personalized Medicines, & Rising Incidence and Prevalence of Hematological Malignancies Fueling Growth - GlobeNewswire Inc.
What institutions are buying Natera Inc. stock nowHigh-yield capital appreciation - jammulinksnews.com
Natera CFO Brophy sold $303k in NTRA stock - Investing.com Australia
Natera CFO Brophy sold $303k in NTRA stock By Investing.com - Investing.com Nigeria
Natera's Prospera™ Heart with DQS: A Game-Changer in Transplant Monitoring - AInvest
PEDAL Study Successful, Shows Monitoring with Prospera™ Kidney Provides Accurate Prognosis of Long-Term Clinical Outcomes Following Rejection; Now Published in AJT - Yahoo Finance
Natera(NTRA) Plunges 1.50% Amid Insider Sales - AInvest
Natera's Trading Volume Surges 62.2% to $257 Million, Ranks 440th Despite Stock Price Decline - AInvest
Natera Inc. Stock Analysis and ForecastFree Stock Movement Tracking - Autocar Professional
SEC Filings Archive 2025-07-22Historical 10-K, 10-Q, 8-K Forms - Stock Titan
Natera CEO Chapman sells $225,928 in shares - Investing.com Australia
Natera CFO Brophy sold $83,852 in NTRA stock - Investing.com
Natera CEO Chapman sells $225,928 in shares By Investing.com - Investing.com UK
Natera president Fesko sells $273k in stock By Investing.com - Investing.com South Africa
Natera director Sheena Jonathan sells $12953 in shares - Investing.com Australia
Natera director Sheena Jonathan sells $12953 in shares By Investing.com - Investing.com Canada
Natera president Fesko sells $273k in stock - Investing.com Australia
Natera Inc: President Moshkevich sells $299k in shares - Investing.com
Natera’s chief legal officer sells $3.4 million in stock - Investing.com
What drives Natera Inc. stock priceMarket-beating returns - jammulinksnews.com
Is Natera Inc. a good long term investmentMassive portfolio appreciation - jammulinksnews.com
0.12%
0.69%
大文字化:
|
ボリューム (24 時間):